Phamraceutical Review (www.pharmareview.wordpress.com). The StarPhoenix; Leader post; www.thestarphoenix.com  has published detail detailed feature of understanding the prescriptive authority for pharmacists. While participating in the “Pharmacist Awareness Week” March 6-11, 2011, Saskatchewan Health Minister Don McMorris has announced that new legislation would come into force March 4, 2011, expanding prescribing authority for Saskatchewan pharmacists, thereby benefiting residents through more efficient and accessible health care services.

The announcement followed a period of time that was needed to receive feedback from interested parties, and to provide pharmacists with all of the tools and assistance they will need for this new role.

Qualified pharmacists now have the authority to prescribe certain drugs under certain conditions. This does not replace the role of your doctor. In fact, it promotes doctor-pharmacist teamwork.

What does prescriptive authority for pharmacists mean?

It means changes to provincial laws to recognize pharmacists as prescribers of drugs.

Under a combination of federal and provincial laws, most drugs are only available by prescription. That is because it takes a trained professional to make the decision that these drugs are appropriate for you. When that decision occurs, that professional can issue a prescription for you when the law permits.

The federal law over regular prescription drugs recognizes pharmacists as prescribers when the same occurs under provincial laws. The laws in Saskatchewan have been changed to allow pharmacists to issue prescriptions under certain circumstances where they are trained to do so.

Does that mean that pharmacists cannot prescribe some drugs?

Yes, the pharmacist cannot prescribe Controlled Substances. They include Narcotics and other moodmodifying drugs that can cause addiction or dependency and abuse. There is other federal law over this group of drugs that impose added conditions over how they are distributed in Canada. This law does not recognize pharmacists in the same way. A special and lengthy federal process must occur before pharmacists can be recognized as prescribers of these substances.

Does this mean that i no longer need a doctor for my medications?

Certainly not. The pharmacist as a prescriber of drugs is NOT intended to replace your doctor or other health care provider. It is quite the opposite. The new laws depend upon a close working relationship between you, your doctor and your pharmacist. The new laws give the pharmacist added tools to work with you and your doctor get the most benefit out of your drug therapy.

Prescribing will be allowed in various circumstances: continuing maintenance therapy, emergencies, incomplete prescriptions, physician’s absence, self-care for minor ailments and seamless care, and when pharmacists have advanced skills. Instead of having to contact your doctor first, your pharmacist can make these prescribing decisions for you and then tell your doctor about them.

Examples include:

– Continuing maintence therapy-you are taking medications medications regularly, your prescription has run out and you can’t get in to see your doctor for several days. Your pharmacist can provide the supply you need until you are able to visit your doctor, and will let your doctor know.

– Emergencies-you take a medication once in a while when needed, or perhaps regularly. You are on a trip, have left this medication at home and need it. Your pharmacist can provide you with a supply until you return home, and will let your doctor know.

– Incomplete prescriptions-sometimes your doctor will inadvertently forget to include some details important to your pharmacist about the drug being prescribed for you. Because your pharmacist knows you and your doctor, and is reasonably certain of your doctor’s intent, s/he fills in the details to complete the prescription. Again, your pharmacist will let your doctor know.

– Physicaian’s absence – doctors sometimes temporally leave their practices for extended periods of time, such as for vacation or education. When that happens, they can leave instructions with your pharmacist to continue the medications for you and other patients if prescriptions run out while s/he is away.

– Seamless care – when you are ill and admitted to a health care facility, your medications can change. If you are transferred from that health care setting to another, for example, are discharged and return to your community, your pharmacist can make sure that your new medication therapy continues uninterrupted. Again, your pharmacist will let your doctor know.

If you have any further questions, ask your pharmacist because “My Pharmacist Knows” or visit www.mypharmacistknows.com.

© Copyright (c) The StarPhoenix

Read more:  https://www.thestarphoenix.com/Understanding+prescriptive+authority+pharmacists/4393754/story.html  

https://www.thestarphoenix.com/Understanding+prescriptive+authority+pharmacists/4393754/story.html#ixzz1IV8XKQep

Pharmaceutical Review (www.pharmareview.wordpress.com).  Pharmacy one in the community chain of pharmacies in Saudi Arabia. The administration of this organization has opened a biggest branch in Jordan. The pictorial review the function is as under;

Founded: August 25, 1949

Location: Andries Bickerweg 5; Den Haag, Netherlands, 2517 JP

About: IPSF is the global student organization that represents more than 350.000 pharmacy students and recent graduates in 84 countries. About us: https://www.ipsf.org/ About the Student Exchange Programme: https://sep.ipsf.org/ Vive la pharmacie!

IPSF represents more than 350,000 pharmacy students and recent graduates in 84 countries worldwide. IPSF is a non-profit, non-political and non-religious volunteer organization.

Company Overview: IPSF is the leading international advocacy organization of pharmacy students promoting improved public health through provision of information, education, networking, and a range of publication and professional activities. The Federation has its secretariat located with the International Pharmaceutical Federation

Awards: Distinguished Practice Award – 2003, International Pharmaceutical Federation

Email: ipsf@ipsf.org

Phone: +31 70 302 1992

Website: https://www.ipsf.org, https://en.wikipedia.org/wiki/IPSF, https://twitter.com/ipsfweb, https://www.scribd.com/ipsfdocs

Karachi (Pharmaceutical Review; www.pharmareview.wordpress.com). Pharmevo Medals Distribution ceremony dated 28 January 2011- held at the  Faculty of Pharmacy, University of Karachi, Pakistan. The pictorial review of this this gracious medal awarding ceremony is as under;

Karachi (Pharmaceutical Review; www.pharmareview.wordpress.com). YDA Pharmacist Sindh is an association of ambitious pharmacist in Pakistan. They are striving to enhance the professional prestige and worth. Their contribution especially significant in community, clinical and pharmaceutical health practice. YDA Pharmacist demanded the fair rights to the Ministry of Health; Govt. of Pakistan for the betterment of the profession as under;

1-      Acknowledge Doctor of Pharmacy (Pharm-D’s) as Primary Health Care Providers as they are most easily accessible in the community to provide Drug information, Treat Basic illness, public awareness, administration of public & preventive health programs & and carry out vaccination.

2-       Direct the authorities concerned (such as those given above) to allow registered Doctor of Pharmacy (Pharm-D) Practitioners to practice supplementary and/or independent prescribing for the common illness & symptoms within the Licensed Pharmacy Premises in the local community.

3-       Provide Sufficient Resources & Seats Professional Higher Post Graduate Education for Pharm D graduates. Like M.S, M.Phil PhD, PGD,s in Clinical Pharmacy, Hospital Pharmacy, and International Degree Courses for Pharmacists in all Health Sciences Institutes in Pakistan

4-       Establishment of Directorate of Pharmacy Services within Ministry of Health in Center and likewise appointment of Assistant Directors Pharmaceutical Services in Districts health offices of Punjab.

5-       Introduce Prescription Recording System in Pakistan to monitor the prescribing practices through pharmacists ensuring Rational Use of Drugs and to prevent the unethically promoted prescribing & misuse of costly medicine.

6-       Establish a National Pharmacy Credentialing Committee (NPCC) responsible for fixing minimum payscale for pharmacist (NLT 30,000 PKR/Month), Competency assessment, continued education, review of appointment procedures, and setting minimum practice & research standards for pharmacists working in community, clinical (Hospitals), academia, and administrative setups (Drug Insp. ADC).

7-      Resume Punjab Govt. Pharmaceutical Care Project of Punjab Government (due to be completed in 2005) and pursue with the appointments of Clinical Pharmacists Positions in every Tehsil Hospital (every 50 beds).

8-      Direct the authorities concerned to ensure provision of Clinical Pharmacy training in the teaching hospitals as per the directive of the Government of the Punjab, Health Department No. SO/(DC) 6-8/2005, dated 17/3/2006.

9-      Direct the authorities concerned i.e. Pharmacy Council of Pakistan to introduce a Board Certification (BCPS) in Clinical Pharmacy Specialties (i.e. Nutrition Pharmacist, Infectious Disease Pharmacist, Pharmacotherapist, Oncology Pharmacist etc ) as being practiced internationally in USA, UK, Netherland, Australia, New Zealand etc. American Indian Health Service (IHS) National Clinical Pharmacy Specialist (NCPS) with prescriptive authority. (Ref: HIS-SGM 10-18-96)

10-  Allow Practicing Pharmacists to be benefited from the National Health Foundation Loan Scheme to set up community pharmacies to promote practice of Pharmacy.

11-  Discontinue the Drug Sale License Wavier for Medical Practitioners running a full scale unsupervised dispensary (actually keeping all medical store items) within Clinic premises keeping almost all medical store items without being accountable under the Drug Act 1976 & Punjab Drug Rules 2007,

12-  Allow Pharmacists practicing in Govt. agencies to claim non practicing Allowance or allow them to practice their profession in evening time.

13-  Direct the Pakistan Pharmacist Association to disseminate its administration at district level by developing a democratic way of electing its executives in a manner as first electing the district representatives for this association at each district of Pakistan who should then select a president and executives for its administration out of those previously elected District representatives of association.

14-  Provide Proper Infra Structure of Jobs for pharmacists, in every Private & Public Sector Hospitals of Pakistan. This should meet International Standards.

15-  University of Health Sciences Lahore for M.Phil , Phd ,Should Provide Seprate Seats for Pharmacists. And conduct Entry test from pharmacy subjects from pharmacists.

16-   Govt. provide Minimum of 200 M.Phil seats for pharmacy graduates in each university. also provide reaserch facilities to pharmacy students. Should Strictly Enforce that Private Universities Must Provide Post Graduate Pharmacy Education, Instead of Only Providing Pharm D. Because They Have Made Pharmacy Education Just A Business.

17-   Govt Should Provide 6 Months on the Study Training in Pharmacy Profession, During Last 6 months of Pharm D , 5 Years Course. As Described in Law of Pak. P.C.P Regulation Jul 23 ,2005 For Conduction of Pharmacy Education . Doctor of Pharmacy Degree. S.R.O 740 (I)/2005

18-  Multinational Pharmaceutical Companies, working in Pakistan, directly of indirectly should separately announce sufficient number of seats for fresh pharmacy graduates. Because these companies are always demanding experienced professionals. Why?

19-  Chief Justice of Pakistan should take self action and banned the all medical stores for sailing prescribed products. Only pharmacy in presence of Pharmacist should be Allowed to sale prescribed products.

20-  Selection on Adhak hospital pharmacist Seats Should is in a clean way. Health dept should publish the vacancy in the news papers and Media. Then they should select the Hospital Pharmacists on Basis of Merit. But Usually The Health Dept and MS of Hospitals Are Appointing Pharmacists in a Illegal way without Announcements in Media. Without Merits. on the Basis of their Personal References, and Relatives. We are Warning them to avoid this further.

Young Doctor Association (Pharmacist)

Sindh, Pakistan

Islamabad (Pharmaceutical review; www.pharmareview.wordpress.com; https://www.ppsc.gop.pk/OmrInstructions.aspx ). The instructions deal with the Computerized Multiple Choice Question (MCQ) answer sheet provided separately. These sheets are graded by a computer, therefore, it is very important that the candidates read and understand these instructions thoroughly before coming for the test.  Non-compliance may lead to improper result.

Instructions for Candidates for Filling Computerized OMR Answer Sheet of Punjab Public Service Commission

information Source: https://www.ppsc.gop.pk/OmrInstructions.aspx

Islamabad (Pharmaceutical Review; www.pharmareview.wordpress.com). Pharmacist Federation of Pakistan arranged a referendum regarding the Drug Rule, 2007. your vote valued for us. Please cast your vote.

[polldaddy poll=4666842]

Islamabad (Pharmaceutical Review; www.pharmareview.wordpress.com). The Director General Health, Maj. Gen. (R) Shahida Malik HI (M), chaired the 206^th meeting of the Central Licensing Board held on 8^th – 9^th June, 2007 in the Committee Room of Ministry of Health, Block-C, Pakistan Secretariat, Islamabad. The Chairperson welcomed all the members of the Board. The following members attended the meeting: –

1.         Maj. Gen. (R) Nasir-ul-Islam HI (M) Rawalpindi.

2.         Lt. Col. Aslam Khan, Classified Medical Specialist Military Hospital,

Rawalpindi.

3.         Brig. Muzammil Hassan Najmi Professor of Pharmacology and Head of Department, Army Medical College, Rawalpindi

3.         Mr. Abdul Latif Sheikh, Director Pharmacy, Nutrition and CSSD Services Aga Khan University Hospital Karachi

5.                  Prof. Dr. Ijaz Ahmad, University of Veterinary and Animal Sciences, Lahore

6.         Prof. Dr.Muhammad Jamshaid, Dean Faculty of Pharmacy, Punjab University, Lahore

7.         Dr. Rana M. Ikhlaq, Deputy Animal Husbandry Commissioner,

Ministry of Food, Agriculture and Livestock, Islamabad.

8. Mr. Arshad M. Tabassum Deputy Secretary, M/o Law Justice & Human Rights Islamabad.

9.         Representative of Director General Health Services, Government of Punjab, Lahore

10.              Mr. Sabir Ali, Chief Drug Inspector Representative of Director General Health Services, Government of NWFP, Peshawar

11.       Mr. Atta-u-Rehman, Chief Drug Inspector Representative of Director General Health Services, Government of Balochistan, Quetta.

12.       Mrs. Yasmeen Abbassi, Controller of Patents Government of Pakistan

Karachi.

13.       Deputy Secretary, M/s Industries & Production Islamabad

14.       Mr. Amanulha, Cost Accountant, Ministry of Health, Islamabad.

15.       Dr. Farnaz Malik,   Secretary Drug Controller, Ministry of Health,

Islamabad.

16.       Mr. Zahid Saeed, Observer Pakistan Pharmaceuticals Manufacturers Association, Karachi

17.       Mr. M. Zafar Mooraj, Observer Advisor, Pharma Bureau, Karachi

18.       Mr. Shami; Chairman, Observer Pakistan Chemists and Druggists Association, Karachi

The meeting started with the recitation of the Verses from the Holy Quran. The following decisions were recorded: –

Item-I              CONFIRMATION OF THE MINUTES OF THE 205^th MEETING.

The Board confirmed the minutes of the 205^th meeting held on 30^th – 31^st March, 2007.

Item-II:           GRANT OF DRUG MANUFACTURING LICENSE (RECOMMENDED)

On the recommendations of the panel of experts the Board approved the grant of Drug Manufacturing Licenses to the following firms: –

Item-II: (B)     GRANT OF ADDITIONAL SECTION (ALREADY LICENSED UNIT RECOMMENDED.

On the recommendations of the panel of experts the Board approved the grant of additional section to the following firm: –

Item-III:(A)                RENEWAL OF DRUG MANUFACTURING LICENSES . RECOMMENDED

On the recommendations of the panel of experts the Board renewed the Drug Manufacturing Licenses to the following firms subject to clearance of C.R.F. accounts and verification of HVAC system. The firms without HVAC facility will be granted renewal till 31^st December, 2007: –

Item-IV:          MISCELLANEOUS

1.                     Change of name.

The Board approved the change of name to the following firm: –

i.          M/s. Spencer Pharma (Pvt) Ltd., D-105, SITE, Karachi

DML # 000272 – Formulation

To

M/s Spencer & Co. (Pakistan) Ltd., D-105, SITE, Karachi

DML # 000272 – Formulation

ii.         M/s Cardex Pharmaceuticals (Pvt.) Ltd.,

38-A, Industrial Estate, Hayatabad, Peshawar

DML # 000511 – Formulation

to

M/s CSH  Pharmaceuticals – North (Pvt) Ltd.,

38-A, Industrial Estate, Hayatabad, Peshawar

DML # 000511 – Formulation

2.         Site Verification.

Following sites verified for establishment of pharmaceutical units have been recommended for approval with certain conditions, are placed before the Board for approval or otherwise: –

3.         Rejection of Application for Renewal of Drug Manufacturing License of M/s Risma Laboratories Karachi.

The case of M/s Risma Laboratories Karachi was discussed in 206^th meeting of the Board with reference to additional surcharge of Rs.45000/- for submitting renewal application 09 days  late after expiry of validity period. The representative of the firm during personal hearing in 204^th meeting agreed to submit the additional fee but did not comply later on.

Decision:

Rejection of renewal application, but the firm next day deposited the dues, therefore the renewal application approved.

4.         Cancellation of Drug Manufacturing License of M/s B.I Drug Company, Mughalpur Lahore.

The case of M/s B.I. Drug Co, Mughalpura Lahore (residential unit) was discussed in the 206^th meeting of the Board with reference to the show cause notice issued to the firm in the light of statement given by the firm regarding establishment of a new pharmaceutical unit at an appropriate site before 31.12.2005. The firm did not submit any reply to the show cause notice issued on 03.08.2006 and the reminders sent to the firm on 17.05.2007 was received back undelivered. The call letter was issued for personal hearing but no response was shown and the area FID Lahore also failed to contact with the management.

Decision:

Rejection of Renewal Application for Drug Manufacturing License.

5.        Renewal of Drug Manufacturing License of M/s Orient Laboratories, Lahore.

The case of M/s Orient Laboratories, Lahore was discussed with reference to the show cause notice issued on 05.05.2006 for Good Manufacturing Practices non compliance and for being in residential area and subsequent decision of the Board in 198^th meeting held on 10.06.2006 to re-inspect the unit.

The panel conducted inspection on 23.04.2007 and reported that no further improvements can be incorporated in the unit being very congested and firm may be allowed to conduct production in the current premises for a period of one year. Accordingly the representative of the firm was called for personal hearing. He requested the Board for grant of two years period for shifting of the unit.

Decision:

Grant of 1½ years period subject to the deregistration of some products and submission of progress report periodically

6.         Renewal of Drug Manufacturing License of M/s Prawa Pharmaceuticals, Azad Kashmir.

The case of M/s Prawa Pharmaceuticals, Azad Kashmir was discussed in 206^th meeting with reference to the explanation issued on 13.01.2007 in the light of panel inspection report. The firm did not submit any reply to the explanation letter and subsequent reminders issued on 28.03.2007 and 07.05.2007. The call letter was issued on 04.06.2007 for personal hearing but no person appeared before the Board.

Decision:

Rejection of Renewal Application for Drug Manufacturing License.

7.         Renewal of Drug Manufacturing License- Pending Inspections.

The cases of pending renewal inspection was discussed in 206^th meeting of the Board in the light of decision of the Board in 204^th meeting  held on 23^rd – 24^th February, 2007 to grant time period till 31^st March 2007 to all those firms whose renewal is pending for more than two years.

Decision:

To strictly adhere to the rule 13 of Drugs (Licensing, Registering & Advertising) Rules, 1976, as panel member has affirmed their availability and also list of firms may be put up to Board who are not ready for inspection for the last 2 years. No fresh registrations would be granted to such companies and validity of DML and cGMP certification will not be granted for participation in the tenders.

8.         Grant of Drug Manufacturing License – M/s Maple Pharmaceuticals (Pvt) Ltd., Karachi.

The case of M/s Maple Pharmaceuticals (Pvt) Ltd. Karachi was discussed in 206^th meeting with reference to the decision taken in 204^th meeting of the Board held on 23^rd – 24^th February, 2007 to conduct inspection for site verification to fulfill all the legal requirements pertaining to the grant of Drug Manufacturing License. The area FID has submitted site verification report of the unit, situated at Plot No.147, Korangi Industrial Area, Karachi and declared site suitable for conducting production of pharmaceuticals products.

Decision:

The Board decided to grant drug manufacturing license under the name M/s Maple Pharmaceuticals (Pvt) Ltd. However to ensure M/s Efroze Chemical Industries as an independent self contained pharma unit inspection  may be conducted for renewal of drug manufacturing license.

9.         Renewal Of Drug Manufacturing Licenses / Grant Of Additional Section of M/s . Venus Pharma Lahore   .

The case of M/s Venus Pharma, Lahore was discussed with reference to the decision of the Board in 204^th meeting held on 23^rd -24^th February, 2007 wherein the firm was directed to suspend production till removal of deficiencies within three moths time and the subsequent inspection conducted on 13.04.2007 by a panel of experts comprising Mr. Hyder Bux Bozdar, DDG (E&M), Mr. Abdul Rashid Sheikh, FID and Mr.Ghazanfar Ali Khan ADC. The panel recommended the renewal of the firm keeping in view the improvements made by the firm to upgrade the facility as per cGMP requirements. However panel did not include a member of the Board.

Decision:

The Board granted permission to resume production in the light of improvements made by the firm. For renewal of drug manufacturing license and grant of additional sections it was decided to re-inspect the firm by a panel including member of the Board.

The meeting ended with the vote of thanks to the Chair.

Gujranwala (HM Faisal; www.pharmareview.com). The Punjab Drug Rule 2007 will barred the drug store that not appoint the pharmacist for the purpose of pharmaceutical community services to sell a total one hundred and forty five (145) life-saving controlled/ narcotics/ potent drugs. It is enforced to accomplish with the internationally accredited standards and provide quality health services. It becomes especially important to promote the rational drug usage and encourage pharmacy culture in Punjab province of Pakistan.

The Punjab governor has notified the Punjab Drugs Rules 2007 under section 44 of the Drugs Act 1976. The rules have been revised after a gap of 19 years. The Wholesale Chemists and Druggists Association’s Lahore chapter president, Nisar Chaudry said that no stakeholder were contacted and persuaded in this context. It an important issue correlated directly with the survival of pharmaceutical merchants.

Moreover; under the new rules, the period of renewal of drug sale license has also been reduced from two to one year. The licensing authority also supposed to bother the inspection report of premises, business procedure and other legal requirements reported by the inspector of drug of that area of jurisprudence. Unavailability of such a large range of pharmaceutical preparations in about 50,000 medical stores in Punjab means generating big health hazard for patients.  Furthermore; there are only very few hundred pharmacies available in the province. Mr. Nisar Chaudhry said the role of wholesalers and distributors had also not explained in the rules as well.
Besides this, the rules say the licensing authority shall not issue a license unless the premises of a pharmacy or medical store is clean and hygienic, has adequate facility for storage of drugs and for their protection from direct sunlight and dust. Under the rules, an aggrieved party may file an appeal to the provincial appellate authority within 30 days of the date of the order issued by the licensing authority. A nine-member provincial quality control board, headed by the provincial health secretary, has been constituted. The board may constitute a committee in a district to be known as the district quality control board. Both boards may meet at least once a month to review the situation of drugs’ quality control.

Before referring a case to a drug court, the provincial or district board shall ascertain the name of the director, partner, and employee of the company who is prima facie responsible for the commission of the offence under the Act or rules and may allow an inspector to institute prosecution against such person. According to the rules, no person shall be appointed as an inspector unless he holds a degree in pharmacy from a university or an institution recognized by the Pharmacy Council of Pakistan and has at least one-year experience in manufacture, sale, testing and analysis of drugs.

Islamabad (www.pharmareview.wordpress.com). The Governor of the Punjab had notified the Punjab Drugs Rules 2007 under section 44 of the Drugs Act 1976. The rules were revised after a 19 years. The Wholesale Chemists and Druggists Association’s had responded aggressively for the withdrawal of this rul. Mr. Nisar Chaudry president of Wholesale Chemists and Druggists Association’s Lahore chapter said that no one has contacted to the stakeholder in this context. It an important issue correlated directly with the survival of pharmaceutical merchants. Under the rule 20 (1) (e) of Punjab drug rule 2007 “a licensee of a medical store shall not sell or store a drug mentioned in the schedule G”. The drugs in this schedule G are as under;

Anti-Leprosy – Rifampicin Injection, Dapsone, Clofamazine, Ethionamide and Prothionemide.

Immunological Products, vaccines, sera\ant-sera – Vaccines of Anthrax, BCG, Botulisms Antitoxin, Cholera, Influenza, Measles, MMR, Rubella, Pneumococcal, Poliomyelitis, Smallpox, Typhoid, Rabiies and Homophiles Influenza Type B, and Immunoglobulins.

Products related with malignant diseases and immunosupression – Folinic Acid, Doxorubicin HCI, Mercaptopurine, Thioguanine, Vincristine, Cisplastin, Busulphan, Carmustine, Lomustine, Cyclophosphamide, Melphalan, Fluorouracil, Mitozantrone, Methottrexate, Vinblastine, Carboplatin, Bleoimycin, Chlorambucil, Dacarbazine, Amasascrine, Azathioprine and Cyclosporin.

Anesthesia and inhalation anesthetics – Propofol, Enfluran, Isofluran, Halotha ne, Bupivacain, Thiopentone, Benzodiazepine, Mitazolam, Naloxone Hcl, Vancuronium, Pancuronium, Tubocuraine, Suxamethonium and Neostigmine.

Antibiotics – Spectinomycin, Teicoplanon, Sodium Fusidate, Vancomycin, Colistin and Impenem.

Inotropics – Primacor, Enoximone and Milrinone.

Injection Prostaglandins – Dinoprotone, Gemeprost AND Carboprost.

Alpha Blocker – Prazosin Hcl, Daxazosing, Indramine and Alfuzosin.

Biotechnological products – Interferon and Erythropoetin.

Narcotics, anti-psychotropic and tricyclic anti-depressant – Morphine, Buprenorphine, Nalbuphine, Fantanil, Pethidine, Lorazepam, Temazepam, Chlorpromazine, Melprobamate, Chlordiazepoxide, Alprozolam, Clonazepam, Flurazepam, Loprazolam, Oxazepam, Amoxapine, Iprine Dole Codine, Pentazocine, Lithium, Dextropropoxyphene, Clomipramine, Mianserin, Maprotiline, Dothiepin, Doxepin, Nortriptyline, Trimiprammine, Tranycypromine, Flupenthixol, Tryptophan, Imipramine and Amipriptyline.

Anti-Viral – Acyclovir, Amantadine Hcl, Famciclovir, Inosine Pranolsex, Zidovudine, Ganciclovir, Idoxuridine, Riavirin, Vidarabrin, Trifluridine and Methisozone.

Thrombolytic Enzymes – Alteplase, Streptokinase, Anislreplase and Urokinase – for dialysis – Peritoneal, Haemodialysis, Hyper tonic solution, Lysine solution and Isotonic solution.

Creams and Aerosols Steroidal Preparations – Methylprednislone, Dexamethasone, Hydrocortisone, Prednisolone, Tramcionolone and Beclomethasone.

Hormones – Vasopressin, Desmopressin, Stanozolol, Nandrolone, Mesterlolone, Finasteride, Finasteriode, Somatropin, Testosterone and Progestrogens.

Eventually the Wholesale Chemists and Druggists Association’s succeeded tang Ministry of Health, Government of the Punjab has issued a notification, printed in the Punjab weekly gazette dated February 10, 2010, page No. 951, in exercise of power conferred upon him under Section 44 of the Drug Act. 1976 (XXXI of 1976) which empower government to make rules under Act. The governor of the Punjab has made amendments in the Punjab Drug Rules, 2007 after previous publication of these amendments. In rule 1, sub rule (3) for word “three” the word “ten” is substituted. Thus; the Punjab Drug Rule 2007 was suspended for ten years further.

In response the this notification the executives of the Pharmacist Federation of Pakistan; Muhammad Ayub  Khan General Secretary (Pakistan), Malik Irshad Hussain President Punjab, Fiaz Ahmad Faizi General Secretary Punjab,  Asad Imran  President Lahore, Dr. Hafiz Muhammad Kashif Secretary Lahore, Dr. Shoaib Zafar President Faisalabad, Aziz Ur Rehman President Sargodha Division, Abdul Rub Mujahid President Bahawalpur, Muhammad Bin Ibrahim President Multan, Malik Muhammad Waheed President Jehlum, Syed Muzzammil Masood Zaidi President Islamabad, Dr. Fowad Ali Bungush Secretary Islamabad, Iradat Hussain President Rawalpindi, Dr. Hafiz Muhammad Abdullah President Bhakkar, Malik Sharif Awan President Gujranwala Division, Dr. Hafiz Muhammad Faisal Secretary Gujranwala, Mr Imran Anwar President Sheikhupura, Dr Kalim Ullah Khan Niazi President Mianwali said these amendments are biased , unfair and based on unrealistic approach of Government of the Punjab. In this way, non-professional personals are secured to sell the life saving drugs. The way of dispensing, distribution and delivery of drugs is totally different than grocery, vegetable, grains and garments. Thus; this amendments should be withdrawn instantly. The non-skilled people shopudl never be allowed to involve in health care practice. Moreover; they have emphasized the government to withdraw this notification soon as possible.